This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
The period for this award will be September 30, 2026, through September 29, 2031.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
122
as of
10/08/2026 at 12:15 pm EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2026-16658 as it appeared on Public Inspection on
08/13/2026 at 8:45 am.
It was viewed
18
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2026-16658 (91 FR 52696)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice.
SUMMARY:
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $1,000,000 for Federal Fiscal Year 2026 funding to International Rescue Committee (IRC), subject to availability of funds. Funding amounts for years 2-5 will be set at continuation. The award will allow CDC to support the implementation of strategies to reduce the transmission of communicable and emerging diseases in mobile populations in overseas settings.
DATES:
The period for this award will be September 30, 2026, through September 29, 2031.
FOR FURTHER INFORMATION CONTACT:
Warren Dalal, Immigrant and Refugee Health Branch, Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30303, Telephone: 404-639-2924, Email:
ies7@cdc.gov.
SUPPLEMENTARY INFORMATION:
The single source award will provide funds to support establishing diagnostic capacity to identify infectious diseases; establishing and enhancing surveillance of communicable diseases (including notifiable conditions) and non-infectious diseases (including mental health or substance use); implementing preparedness and control measures to prevent and control infectious diseases with government agencies, NGOs, and other organizations that provide healthcare in globally mobile populations; improving data management and systems impacting
( printed page 52697)
public health and health care in these populations; and developing training materials, educational activities, and communications for globally mobile populations (including mobile phone updates and notifications in appropriate languages) to increase awareness of infectious disease prevention.
IRC is in a unique position to conduct this work, as it works in more than 30 crisis-affected countries, developing relationships with other non-governmental organizations and providing healthcare and public health services to globally mobile populations in refugee camps, including hospital inpatient and outpatient services, vital registries, disease surveillance, community outreach, and public health campaigns to prevent vaccine-preventable and vector-borne diseases. In many of these situations, IRC has been designated the healthcare implementing partner by the United Nations High Commissioner for Refugees, and no other organization can take over this role. Therefore, they are uniquely positioned to support CDC's mission to prevent, detect, and respond to outbreak prone diseases in these populations.
Summary of the Award
Recipient:
IRC.
Purpose of the award:
The purpose of this award is to support the implementation of strategies to reduce the transmission of communicable and emerging diseases in mobile populations overseas.
Authority:
This program is authorized under 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. 241(a) and 247b(k)(2)], as amended. Section 307 Public Health Service Act, [42 U.S.C. 2421].
Period of performance:
September 30, 2026, through September 29, 2031.
Jamie Legier,
Chief Grants Management Officer, Centers for Disease Control and Prevention.